Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer open access plus

Volume:12   Issue:2
Pp: 107-123
S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge
DOI: 10.2174/156800912799095144

Order Reprints Order Eprints

Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy

Volume:12   Issue:2
Pp: 124-131
P. Cejas, M. Lopez-Gomez, C. Aguayo, R. Madero, J. Moreno-Rubio, J. de Castro Carpeno, C. Belda-Iniesta, J. Barriuso, V. Moreno Garcia, E. Diaz, E. Burgos, M. Gonzalez-Baron and J. Feliu
DOI: 10.2174/156800912799095162

Order Reprints Order Eprints

Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal Adenocarcinoma

Volume:12   Issue:2
Pp: 132-143
E. Piazuelo, S. Santander, C. Cebrian, P. Jimenez, C. Pastor, M. A. Garcia-Gonzalez, F. Esteva, P. Esquivias, J. Ortego and A. Lanas
DOI: 10.2174/156800912799095199

Order Reprints Order Eprints

Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer open access plus

Volume:12   Issue:2
Pp: 170-184
S. Tan, E. G.E. de Vries, A. G.J. van der Zee and S. de Jong
DOI: 10.2174/156800912799095135

Order Reprints Order Eprints